These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 1819212

  • 1. Urinary levels of interleukin-6 and disease activity in patients with IgA nephropathy.
    Tomino Y, Funabiki K, Ohmuro H, Shimizu M, Yokoyama K, Shirato I, Shirai T, Takahashi M, Koide H.
    Am J Nephrol; 1991; 11(6):459-64. PubMed ID: 1819212
    [Abstract] [Full Text] [Related]

  • 2. Urinary levels of interleukin-8 (IL-8) and disease activity in patients with IgA nephropathy.
    Huang F, Horikoshi S, Kurusu A, Shibata T, Suzuki S, Funabiki K, Shirato I, Tomino Y.
    J Clin Lab Anal; 2001; 15(1):30-4. PubMed ID: 11170231
    [Abstract] [Full Text] [Related]

  • 3. Urinary levels of monocyte chemoattractant protein (MCP)-1 and disease activity in patients with IgA nephropathy.
    Saitoh A, Suzuki Y, Takeda M, Kubota K, Itoh K, Tomino Y.
    J Clin Lab Anal; 1998; 12(1):1-5. PubMed ID: 9484662
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of interleukin-2 receptor and disease activity in patients with IgA nephropathy.
    Tomino Y, Ozaki T, Koide H, Takahashi M, Ito K.
    J Clin Lab Anal; 1989; 3(6):355-9. PubMed ID: 2482345
    [Abstract] [Full Text] [Related]

  • 5. The prognostic significance of urinary interleukin 6 in IgA nephropathy.
    Dohi K, Iwano M, Muraguchi A, Horii Y, Hirayama T, Ogawa S, Shiiki H, Hirano T, Kishimoto T, Ishikawa H.
    Clin Nephrol; 1991 Jan; 35(1):1-5. PubMed ID: 2007290
    [Abstract] [Full Text] [Related]

  • 6. [Study of correlation between urinary IL-6 level and mesangial lesion in childhood onset IgA nephropathy].
    Akutsu Y.
    Hokkaido Igaku Zasshi; 1994 Jul; 69(4):686-96. PubMed ID: 7959587
    [Abstract] [Full Text] [Related]

  • 7. Urinary interleukin-6 (IL-6) and transforming growth factor (TGF-β) levels in corticosteroidtreated patients with IgA nephropathy.
    Kalliakmani P, Nakopoulou L, Tsakas S, Gerolymos M, Papasotiriou M, Goumenos DS.
    Clin Nephrol; 2011 Aug; 76(2):144-50. PubMed ID: 21762647
    [Abstract] [Full Text] [Related]

  • 8. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
    Segarra-Medrano A, Carnicer-Caceres C, Valtierra-Carmeno N, Agraz-Pamplona I, Ramos-Terrades N, Jatem Escalante E, Ostos-Roldan E.
    Nefrologia; 2017 Aug; 37(5):531-538. PubMed ID: 28946966
    [Abstract] [Full Text] [Related]

  • 9. Detection of 'activated platelets' in the urinary sediments using a scanning electron microscope in patients with IgA nephropathy.
    Shirato I, Tomino Y, Koide H.
    Am J Nephrol; 1990 Aug; 10(3):186-90. PubMed ID: 2200268
    [Abstract] [Full Text] [Related]

  • 10. Detection of activated platelets in urinary sediments by immunofluorescence using monoclonal antibody to human platelet GMP-140 in patients with IgA nephropathy.
    Tomino Y, Tsushima Y, Ohmuro H, Shimizu M, Kuramoto T, Shirato I, Koide H.
    J Clin Lab Anal; 1993 Aug; 7(6):329-33. PubMed ID: 7506303
    [Abstract] [Full Text] [Related]

  • 11. Serum levels of soluble Fas and disease activity in patients with IgA nephropathy.
    Shou I, Tashiro K, Kurusu A, Kaneko S, Hayashi T, Fukui M, Shirato I, Kubota K, Tomino Y.
    Nephron; 1999 Aug; 81(4):387-92. PubMed ID: 10095173
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of urinary interleukin 6 in patients with IgA nephropathy: an 8-year follow-up study.
    Harada K, Akai Y, Kurumatani N, Iwano M, Saito Y.
    Nephron; 2002 Dec; 92(4):824-6. PubMed ID: 12399627
    [Abstract] [Full Text] [Related]

  • 13. Correlations among expression of glomerular intercellular adhesion molecule 1 (ICAM-1), levels of serum soluble ICAM-1, and renal histopathology in patients with IgA nephropathy.
    Nguyen TT, Shou I, Funabiki K, Shirato I, Kubota K, Tomino Y.
    Am J Nephrol; 1999 Dec; 19(4):495-9. PubMed ID: 10460941
    [Abstract] [Full Text] [Related]

  • 14. [Serum and urinary interleukin-6 levels in patients with primary glomerulonephritis].
    Hrvacević R, Topalov D, Stojanović R, Lilić D, Dimitrijević J, Maksić Dj, Marić M.
    Srp Arh Celok Lek; 1996 Dec; 124 Suppl 1():40-2. PubMed ID: 9102925
    [Abstract] [Full Text] [Related]

  • 15. Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy.
    Ranieri E, Gesualdo L, Petrarulo F, Schena FP.
    Kidney Int; 1996 Dec; 50(6):1990-2001. PubMed ID: 8943482
    [Abstract] [Full Text] [Related]

  • 16. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy.
    Stangou M, Alexopoulos E, Papagianni A, Pantzaki A, Bantis C, Dovas S, Economidou D, Leontsini M, Memmos D.
    Nephrology (Carlton); 2009 Sep; 14(6):613-20. PubMed ID: 19143943
    [Abstract] [Full Text] [Related]

  • 17. [Establishment of enzyme-linked immunosorbent assay (ELISA) for measuring human urinary uromodulin and application of the method in patients with IgA nephropathy].
    Liu Y, Chen YQ, Zhou JJ, Han J, Liang Y, Li XY, Zhang H.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr 18; 44(2):307-10. PubMed ID: 22517010
    [Abstract] [Full Text] [Related]

  • 18. Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura.
    Wu TH, Wu SC, Huang TP, Yu CL, Tsai CY.
    Nephron; 1996 Apr 18; 74(1):79-88. PubMed ID: 8883024
    [Abstract] [Full Text] [Related]

  • 19. [Prognostic values of serum concentration and urinary excretion of interleukin-1 receptor antagonist and tumor necrosis factor receptors type I and II in patients with IGA nephropathy].
    Zwiech R, Kacprzyk F, Szuflet A, Nowicki M.
    Pol Arch Med Wewn; 2005 Apr 18; 113(4):326-33. PubMed ID: 16209246
    [Abstract] [Full Text] [Related]

  • 20. Urinary liver-type fatty acid-binding protein: discrimination between IgA nephropathy and thin basement membrane nephropathy.
    Nakamura T, Sugaya T, Ebihara I, Koide H.
    Am J Nephrol; 2005 Apr 18; 25(5):447-50. PubMed ID: 16118482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.